Patricia Weeks of Fox Chase Cancer Center Named Chair of the Board for BioStrategy Partners
PHILADELPHIA (December 14, 2005) - Patricia Weeks, vice president for planning and business Fox Chase Cancer Center, has been named chair of the board for BioStrategy Partners. BioStrategy Partners provides pre-seed and early-stage life sciences companies in the tri-state region with the tools they need to grow their businesses to the next level.
Weeks was appointed to this position because of her unique sense of the earliest of life sciences and their needs within the community. "I have had the pleasure of experiencing Pat's innovative, exacting and hands-on approach to our business issues as a Board member; undoubtedly Pat comes with both the credibility and the leadership skills to Chair our Board as BioStrategy moves forward and meets the challenges of its new initiatives in the months and years to come," said Carolyn D'Arville, president of BioStrategy Partners.
"The mentoring and service that BioStrategy Partners provides is essential to companies that are in the early stages of development. The scientists who made the discovery that fuels the work create many of these companies and while they're great researchers, they may not have the business skill- set to market their company or go after funding. BioStrategy Partners can provide sophisticated guidance in these areas," said Weeks.
At Fox Chase Cancer Center, Weeks is responsible for the negotiation of all commercial agreements, as well as the management of the Center's technology portfolio.
Weeks is a past president of the Association of University Technology Managers (AUTM), which promotes, supports and enhances the global academic technology transfer profession through internal and external education, training and communication. In addition, she has served as President-Elect, VP for Professional Development, as well as the VP of the Eastern Region of this organization.
As a respected expert, Weeks has been an invited to speak at many national and international conferences, symposia and workshops on the subject of the transfer of academic technology to the commercial sector. She is also past chair of the executive committee of START, a consortium of area academic organizations, the Ben Franklin Partnership, British Technology Group and venture capital firms whose aim was enhanced technology transfer.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.